Synapse

← Adrian L. Harris

Papers by Adrian L. Harris

Page 6 · newest first

  1. Targeting DLL4 in Tumors Shows Preclinical Activity But Potentially Significant ToxicityFuture Oncology · 2010
  2. Overexpression of POLQ Confers a Poor Prognosis in Early Breast Cancer PatientsOncotarget · 2010
  3. Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoterENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2010
  4. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomesBlood · 2010
  5. Expression of key hypoxia sensing prolyl‐hydroxylases PHD1, ‐2 and ‐3 in pancreaticobiliary cancerHistopathology · 2010
  6. Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell CarcinomaENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2010
  7. Development of a new bimodal imaging methodology: a combination of fluorescence microscopy and high‐resolution secondary ion mass spectrometryJournal of Microscopy · 2010
  8. Upregulation of ADAM proteases and HER ligands through a feedback loop mediates acquired resistance to trastuzumab in HER2-amplified breast cancerBreast Cancer Research · 2010
  9. MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCUSHILAP Revista de lepidopterología · 2010
  10. hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancerCancer · 2010
  11. Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic InstabilityCancer Research · 2010
  12. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metageneBritish Journal of Cancer · 2010
  13. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotypeBritish Journal of Cancer · 2010
  14. Effects of HIF-1 and HIF2 on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 XenograftsJournal of Oncology · 2010
  15. Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cellsHaematologica · 2009
  16. Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxiaCell Cycle · 2009
  17. Exon Array Analysis of Head and Neck Cancers Identifies a Hypoxia Related Splice Variant of LAMA3 Associated with a Poor PrognosisPLoS Computational Biology · 2009
  18. Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of BevacizumabClinical Cancer Research · 2009
  19. Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder CancerCancer Research · 2009
  20. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancerBritish Journal of Cancer · 2009
  21. Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosisJournal of Cellular and Molecular Medicine · 2009
  22. Role of Hypoxia‐Inducible Factors in Epigenetic Regulation via Histone DemethylasesAnnals of the New York Academy of Sciences · 2009
  23. Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissuesBMC Genomics · 2009
  24. Contribution of Granulocyte Colony-Stimulating Factor to the Acute Mobilization of Endothelial Precursor Cells by Vascular Disrupting AgentsCancer Research · 2009
  25. Targeting the hypoxia-inducible factor (HIF) pathway in cancerExpert Reviews in Molecular Medicine · 2009
  26. A First-in-Man Phase I and Pharmacokinetic Study on CHR-2797 (Tosedostat), an Inhibitor of M1 Aminopeptidases, in Patients with Advanced Solid TumorsClinical Cancer Research · 2009
  27. Zinc presence in invasive ductal carcinoma of the breast and its correlation with oestrogen receptor statusPhysics in Medicine and Biology · 2009
  28. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaBlood · 2009
  29. The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell GrowthsJournal of Biological Chemistry · 2009
  30. Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosisBritish Journal of Cancer · 2009
  31. The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with BortezomibCancer Research · 2009
  32. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategiesJournal of Enzyme Inhibition and Medicinal Chemistry · 2009
  33. Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer PatientsClinical Cancer Research · 2009
  34. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapyBritish Journal of Cancer · 2009
  35. Lactate Dehydrogenase 5 Expression in Squamous Cell Head and Neck Cancer Relates to Prognosis following Radical or Postoperative RadiotherapyOncology · 2009
  36. Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast CancerJournal of Clinical Oncology · 2008
  37. Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid TumorsClinical Cancer Research · 2008
  38. Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid TumorsClinical Cancer Research · 2008
  39. Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer typesBritish Journal of Cancer · 2008
  40. Aminoglutethimide – A New Endocrine Therapy in Breast CancerExperimental Cell Biology · 2008
  41. HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer CellsPLoS ONE · 2008
  42. Hypoxia response and microRNAs: no longer two separate worldsJournal of Cellular and Molecular Medicine · 2008
  43. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancerBritish Journal of Cancer · 2008
  44. Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastasesBritish Journal of Cancer · 2008
  45. Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancerBritish Journal of Cancer · 2008
  46. The distribution of trace elements Ca, Fe, Cu and Zn and the determination of copper oxidation state in breast tumour tissue using μSRXRF and μXANESView · 2008
  47. Tumor-associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-dimensional Multicellular GrowthsJournal of Biological Chemistry · 2008
  48. Phosphorylated VEGFR2/KDR receptors are widely expressed in B‐cell non‐Hodgkin's lymphomas and correlate with hypoxia inducible factor activationHematological Oncology · 2008
  49. A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast CancerClinical Cancer Research · 2008
  50. Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast CancerClinical Cancer Research · 2008